{"nct_id":"NCT01034657","title":"LBH589 Alone or in Combination With Erythropoietin Stimulating Agents (ESA) in Patients With Low or Int-1 Risk Myelodysplastic Syndromes (MDS)","status":"TERMINATED","status_verified_date":"2017-08","start_date":"2009-11","start_date_type":null,"primary_completion_date":"2012-08","primary_completion_date_type":"ACTUAL","completion_date":"2012-08","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}